LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Insider & Institutional Ownership 54.3% of LENZ […]